An experimental vaccine, designed to enlist the body's own immune system to target cancer cells, has shown promise for treating and preventing cancer in mice.
The vaccine was created to target a gene called KRAS that is involved in the development of many types of cancer, including lung, bowel and pancreatic cancer.
Researchers from the same team have also found a new way to spot and treat aggressive forms of lung cancers that are able to evade the body's immune system.
Both studies will be presented on Sunday at the 32nd EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics, which is taking place online.
Scientists have known for decades that the KRAS gene goes wrong - or mutates - in many cancers. However, until now, researchers have struggled to find a way to turn this knowledge into an effective treatment.
sciencecodex.com/vaccine-tr...
European Organisation for Research and Treatment of Cancer: